Clinical Trial Update: Immune Response to Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating immune response to a supplemental rotavirus vaccine dose given at 9 months alongside local vaccines in Mali; results completed with pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea Rotavirus

Snippet

Sponsor: PATH | Conditions: Diarrhea Rotavirus | Phase 4 | Status: COMPLETED | Results posted: 2018-12-07